H1 Closes $58M Series B Funding


H1, a NYC-based global platform for the healthcare ecosystem, closed a $58m Series B round of funding.

The round was co-led by IVP and Menlo Ventures with participation from Transformation Capital, Lux Capital, Lead Edge Capital, Novartis dRx and YC. In conjunction with the funding, Somesh Dash, General Partner at IVP, is joining the H1 board of directors. IVP Partner Michael Miao, Menlo Ventures Partner JP Sanday and Lux Partner Deena Shakir are also joining as board observers.

Led by co-founders Ariel Katz and Ian Sax, H1 connects parties within the healthcare ecosystem. Its platform empowers the life sciences industry with 9 million healthcare provider (HCP) profiles worldwide from professional, scholarly, clinical, and social sources, as well as complete global and therapeutic area coverage. H1 utilizes data science and intelligence to draw out unique insights and accelerate outcomes for medical affairs, commercial and marketing organizations. .

The company has reached growth in 2020. Following its Series A announcement in April 2020 of $12.9m, H1 has grown from approximately 100 employees globally to nearly 250 and anticipates expanding its headcount significantly over the next year, including further expansion into Europe and Asia. The company counts 13 of the top 20 pharmaceutical companies as its clients.



Join the discussion